Most Popular Choices
Share on Facebook 11 Printer Friendly Page More Sharing Summarizing
OpEdNews Op Eds      

Include males too in addressing human papilloma virus and related cancers

By       (Page 4 of 7 pages) Become a premium member to see this article and all articles as one long page.   No comments

Citizen News Service - CNS
Follow Me on Twitter     Message Citizen News Service - CNS
Become a Fan
  (2 fans)

Those with persistent HPV infection may need a specialised follow up medical examination with colposcopy (medical experts examine with an equipment for any HPV-related changes or abnormalities in vulva, vagina or cervix of women) or anoscopy (medical experts examine with an equipment for any HPV-related changes or abnormalities in anus or rectum). If any changes or abnormalities, further appropriate medical treatment is required.

"We need more medical centres for anoscopy," said Dr Prapti Gilada whose study participants may require further follow up. Her centre is continuing to follow up with all the study participants, one of whom has become HPV negative during the study.

Dr Smita Joshi is a widely recognised colposcopy trainer too. "We have screened over 40,000 women for HPV and cervical cancer and managed them appropriately as per the WHO latest guidelines." Her centre at Prayas is a recognised colposcopy centre too which has trained several medical professionals including gynaecologists from within India and other countries too.

She appeals for financial resources to scale up trainings of medical professionals in India and other countries which would go a long way in strengthening capacities and competencies towards addressing HPV and related cancers.

Addressing HPV lacks ambition

Governments have promised to eliminate cervical cancer by end of this century. In order to be on track towards cervical cancer elimination, all countries must reach and maintain an incidence rate of below 4 per 100,000 women. Achieving that goal rests on 3 key pillars and their corresponding targets to be achieved by 2030 so that countries are on track towards eliminating cervical cancer by end of the century.

- vaccination: 90% of all eligible young people must be fully vaccinated with the HPV vaccine by the age of 15

- screening: 70% of women should be screened using a high-performance test by the age of 35, and again by the age of 45

- treatment: 90% of women with pre-cancer treated and 90% of women with invasive cancer managed.

Next Page  1  |  2  |  3  |  4  |  5  |  6  |  7

(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).

Rate It | View Ratings

Citizen News Service - CNS Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Citizen News Service (CNS) specializes in in-depth and rights-based, health and science journalism. For more information, please contact: www.citizen-news.org or @cns_health or www.facebook.com/cns.page
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter

Name
Email
   (Opens new browser window)
 

Most Popular Articles by this Author:     (View All Most Popular Articles by this Author)

The chasm between TB and HIV continues

Management of respiratory diseases beyond drugs: Pulmonary Rehabilitation

Oxygen therapy is like a prescription drug: Use it rationally

New funding boosts research for controlling TB, malaria, dengue and leishmaniasis

Another feather in the cap of treatment as HIV prevention

Why are shorter, safer and more effective treatments for drug-resistant TB not being rolled out?

To View Comments or Join the Conversation:

Tell A Friend